Skip to main content
. 2016 May 16;10(4):324–337. doi: 10.1177/1753465816646320

Figure 4.

Figure 4.

Mean forced expiratory volume in 1 second (FEV1) (with 95% confidence interval) on day 0 predose and at 2-hours postdose thereafter during the core study (per-protocol set).

FP/FORM, fluticasone propionate/formoterol fumarate; FP/SAL, fluticasone propionate/salmeterol xinafoate. Core study: day 0 to day 84.